IGF2BP1 and neoplasm: To assess IGF2BP1’s role in tumor growth and immune evasion in vivo, we used ID8 cells—a syngeneic murine model of HGSC with CRISPR-Cas9-mediated knockout of Trp5336—that retain Igf2bp1-driven immune evasion in vitro (Supplementary Fig. S2g).